Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 584 entries
Sorted by: Best Match Show Resources per page
Excess Muscle FDG Uptake in an Euglycaemic Patient That Is Corrected by Fasting.

Clinical positron imaging : official journal of the Institute for Clinical P.E.T

Akhurst T, Boland P, Macapinlac H, Finn R, Yeung HW, Squire O, Larson SM.
PMID: 14516602
Clin Positron Imaging. 1998 Mar;1(2):131-133. doi: 10.1016/s1095-0397(98)00008-9.

A 61-year-old non-diabetic woman underwent a non-diagnostic FDG PET study due to ingestion of milk and sugar 150 minutes prior to injection of FDG despite being euglycaemic. A repeat study 2 days later showed 4 pathological foci of FDG...

Cite
Akhurst T, Boland P, Macapinlac H, et al. Excess Muscle FDG Uptake in an Euglycaemic Patient That Is Corrected by Fasting. Clin Positron Imaging. 1998;1(2):131-133doi: 10.1016/s1095-0397(98)00008-9.
Akhurst, T., Boland, P., Macapinlac, H., Finn, R., Yeung, H. W., Squire, O., & Larson, S. M. (1998). Excess Muscle FDG Uptake in an Euglycaemic Patient That Is Corrected by Fasting. Clinical positron imaging : official journal of the Institute for Clinical P.E.T, 1(2), 131-133. https://doi.org/10.1016/s1095-0397(98)00008-9
Akhurst, Timothy, et al. "Excess Muscle FDG Uptake in an Euglycaemic Patient That Is Corrected by Fasting." Clinical positron imaging : official journal of the Institute for Clinical P.E.T vol. 1,2 (1998): 131-133. doi: https://doi.org/10.1016/s1095-0397(98)00008-9
Akhurst T, Boland P, Macapinlac H, Finn R, Yeung HW, Squire O, Larson SM. Excess Muscle FDG Uptake in an Euglycaemic Patient That Is Corrected by Fasting. Clin Positron Imaging. 1998 Mar;1(2):131-133. doi: 10.1016/s1095-0397(98)00008-9. PMID: 14516602.
Copy Download .nbib Format: NLM
Studies of a molecular hourglass: synthesis and magnetic characterisation of a cyclic dodecanuclear {Cr10Cu2} complex.

Chemistry (Weinheim an der Bergstrasse, Germany)

Shanmugam M, Engelhardt LP, Larsen FK, Luban M, McInnes EJ, Muryn CA, Overgaard J, Rentschler E, Timco GA, Winpenny RE.
PMID: 17009364
Chemistry. 2006 Nov 06;12(32):8267-75. doi: 10.1002/chem.200600827.

The synthesis, structure, EPR, and magnetic studies of two dodecanuclear heterometallic cyclic clusters are reported. The compounds have the general formula [R(2)NH(2)](2)[Cr(10)Cu(2)F(14)(O(2)CCMe(3))(22)] (R=Me, 1 or iPr, 2). Both structures contain an array of metal centers which describe an approximate...

Cite
Shanmugam M, Engelhardt LP, Larsen FK, et al. Studies of a molecular hourglass: synthesis and magnetic characterisation of a cyclic dodecanuclear {Cr10Cu2} complex. Chemistry. 2006;12(32):8267-75doi: 10.1002/chem.200600827.
Shanmugam, M., Engelhardt, L. P., Larsen, F. K., Luban, M., McInnes, E. J., Muryn, C. A., Overgaard, J., Rentschler, E., Timco, G. A., & Winpenny, R. E. (2006). Studies of a molecular hourglass: synthesis and magnetic characterisation of a cyclic dodecanuclear {Cr10Cu2} complex. Chemistry (Weinheim an der Bergstrasse, Germany), 12(32), 8267-75. https://doi.org/10.1002/chem.200600827
Shanmugam, Muralidharan, et al. "Studies of a molecular hourglass: synthesis and magnetic characterisation of a cyclic dodecanuclear {Cr10Cu2} complex." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 12,32 (2006): 8267-75. doi: https://doi.org/10.1002/chem.200600827
Shanmugam M, Engelhardt LP, Larsen FK, Luban M, McInnes EJ, Muryn CA, Overgaard J, Rentschler E, Timco GA, Winpenny RE. Studies of a molecular hourglass: synthesis and magnetic characterisation of a cyclic dodecanuclear {Cr10Cu2} complex. Chemistry. 2006 Nov 06;12(32):8267-75. doi: 10.1002/chem.200600827. PMID: 17009364.
Copy Download .nbib Format: NLM
Absence of antitumor activity with prednisone in patients with progressive androgen-independent prostate carcinoma.

Urologic oncology

Amato RJ, Ellerhorst J, Finn L, Logothetis CJ.
PMID: 21224139
Urol Oncol. 1996 Mar-Apr;2(2):70-3. doi: 10.1016/s1078-1439(96)00045-2.

Corticosteroids are reported to have antitumor activity in patients with androgen-independent prostate carcinoma (AIPCa). This trial, a phase II trial of daily oral prednisone 10 mg four times per day for 56 consecutive days, was designed to confirm this...

Cite
Amato RJ, Ellerhorst J, Finn L, et al. Absence of antitumor activity with prednisone in patients with progressive androgen-independent prostate carcinoma. Urol Oncol. 1996;2(2):70-3doi: 10.1016/s1078-1439(96)00045-2.
Amato, R. J., Ellerhorst, J., Finn, L., & Logothetis, C. J. (1996). Absence of antitumor activity with prednisone in patients with progressive androgen-independent prostate carcinoma. Urologic oncology, 2(2), 70-3. https://doi.org/10.1016/s1078-1439(96)00045-2
Amato, R J, et al. "Absence of antitumor activity with prednisone in patients with progressive androgen-independent prostate carcinoma." Urologic oncology vol. 2,2 (1996): 70-3. doi: https://doi.org/10.1016/s1078-1439(96)00045-2
Amato RJ, Ellerhorst J, Finn L, Logothetis CJ. Absence of antitumor activity with prednisone in patients with progressive androgen-independent prostate carcinoma. Urol Oncol. 1996 Mar-Apr;2(2):70-3. doi: 10.1016/s1078-1439(96)00045-2. PMID: 21224139.
Copy Download .nbib Format: NLM
Engineering superposition states and tailored probes for nanoresonators via open-loop control.

Physical review letters

Jacobs K, Tian L, Finn J.
PMID: 19257548
Phys Rev Lett. 2009 Feb 06;102(5):057208. doi: 10.1103/PhysRevLett.102.057208. Epub 2009 Feb 06.

We show that a nanoresonator can be prepared in mesoscopic superposition states merely by monitoring a qubit coupled to the square of the resonator's position. This works for thermal initial states, and does not require a third-order nonlinearity. The...

Cite
Jacobs K, Tian L, Finn J. Engineering superposition states and tailored probes for nanoresonators via open-loop control. Phys Rev Lett. 2009;102(5):057208doi: 10.1103/PhysRevLett.102.057208.
Jacobs, K., Tian, L., & Finn, J. (2009). Engineering superposition states and tailored probes for nanoresonators via open-loop control. Physical review letters, 102(5), 057208. https://doi.org/10.1103/PhysRevLett.102.057208
Jacobs, Kurt, et al. "Engineering superposition states and tailored probes for nanoresonators via open-loop control." Physical review letters vol. 102,5 (2009): 057208. doi: https://doi.org/10.1103/PhysRevLett.102.057208
Jacobs K, Tian L, Finn J. Engineering superposition states and tailored probes for nanoresonators via open-loop control. Phys Rev Lett. 2009 Feb 06;102(5):057208. doi: 10.1103/PhysRevLett.102.057208. Epub 2009 Feb 06. PMID: 19257548.
Copy Download .nbib Format: NLM
Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agents.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses

Mazzulli T, Skulnick M, Small G, Marshall W, Hoban DJ, Zhanel GG, Finn S, Low DE.
PMID: 18159352
Can J Infect Dis. 2001 Sep;12(5):289-92. doi: 10.1155/2001/601743.

OBJECTIVE: To determine the susceptibility of community outpatient Gram-negative urinary tract isolates to mecillinam and other commonly used oral agents.DESIGN AND SETTING: The study was a laboratory-based study of consecutive Gram-negative urinary tract isolates. Only those isolates considered to...

Cite
Mazzulli T, Skulnick M, Small G, et al. Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agents. Can J Infect Dis. 2001;12(5):289-92doi: 10.1155/2001/601743.
Mazzulli, T., Skulnick, M., Small, G., Marshall, W., Hoban, D. J., Zhanel, G. G., Finn, S., & Low, D. E. (2001). Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agents. The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses, 12(5), 289-92. https://doi.org/10.1155/2001/601743
Mazzulli, T, et al. "Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agents." The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses vol. 12,5 (2001): 289-92. doi: https://doi.org/10.1155/2001/601743
Mazzulli T, Skulnick M, Small G, Marshall W, Hoban DJ, Zhanel GG, Finn S, Low DE. Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agents. Can J Infect Dis. 2001 Sep;12(5):289-92. doi: 10.1155/2001/601743. PMID: 18159352; PMCID: PMC2094837.
Copy Download .nbib Format: NLM
How molecular oxygen binds to bis[trifluoroacetylacetonato(-1)]cobalt(II)--ab initio and density functional theory studies.

Dalton transactions (Cambridge, England : 2003)

Kubas A, Hartung J, Fink K.
PMID: 21796311
Dalton Trans. 2011 Nov 14;40(42):11289-95. doi: 10.1039/c1dt10724k. Epub 2011 Jul 28.

Cobalt(II) diketonate complexes, such as bis[trifluoroacetylacetonato(-1)]cobalt(II) [Co(tfa)(2)], catalyze the aerobic oxidation of alkenols into functionalized tetrahydrofurans. To gain insight into activation of triplet dioxygen by Co(tfa)(2) in a protic solvent, as used in oxidation catalysis, the electronic structure of...

Cite
Kubas A, Hartung J, Fink K. How molecular oxygen binds to bis[trifluoroacetylacetonato(-1)]cobalt(II)--ab initio and density functional theory studies. Dalton Trans. 2011;40(42):11289-95doi: 10.1039/c1dt10724k.
Kubas, A., Hartung, J., & Fink, K. (2011). How molecular oxygen binds to bis[trifluoroacetylacetonato(-1)]cobalt(II)--ab initio and density functional theory studies. Dalton transactions (Cambridge, England : 2003), 40(42), 11289-95. https://doi.org/10.1039/c1dt10724k
Kubas, Adam, et al. "How molecular oxygen binds to bis[trifluoroacetylacetonato(-1)]cobalt(II)--ab initio and density functional theory studies." Dalton transactions (Cambridge, England : 2003) vol. 40,42 (2011): 11289-95. doi: https://doi.org/10.1039/c1dt10724k
Kubas A, Hartung J, Fink K. How molecular oxygen binds to bis[trifluoroacetylacetonato(-1)]cobalt(II)--ab initio and density functional theory studies. Dalton Trans. 2011 Nov 14;40(42):11289-95. doi: 10.1039/c1dt10724k. Epub 2011 Jul 28. PMID: 21796311.
Copy Download .nbib Format: NLM
Fat embolism following an epileptic seizure.

British medical journal

Kaufman HD, Finn R, Bourdillon RE.
PMID: 20790946
Br Med J. 1966 Apr 30;1(5495):1089. doi: 10.1136/bmj.1.5495.1089.

No abstract available.

Cite
Kaufman HD, Finn R, Bourdillon RE. Fat embolism following an epileptic seizure. Br Med J. 1966;1(5495):1089doi: 10.1136/bmj.1.5495.1089.
Kaufman, H. D., Finn, R., & Bourdillon, R. E. (1966). Fat embolism following an epileptic seizure. British medical journal, 1(5495), 1089. https://doi.org/10.1136/bmj.1.5495.1089
Kaufman, H D, et al. "Fat embolism following an epileptic seizure." British medical journal vol. 1,5495 (1966): 1089. doi: https://doi.org/10.1136/bmj.1.5495.1089
Kaufman HD, Finn R, Bourdillon RE. Fat embolism following an epileptic seizure. Br Med J. 1966 Apr 30;1(5495):1089. doi: 10.1136/bmj.1.5495.1089. PMID: 20790946; PMCID: PMC1843977.
Copy Download .nbib Format: NLM
Activated sludge treatment of synthetic wastewater containing pentachlorophenol.

Biotechnology and bioengineering

Edgehill RU, Finn RK.
PMID: 18574814
Biotechnol Bioeng. 1983 Sep;25(9):2165-76. doi: 10.1002/bit.260250905.

Activated sludge treatment of a pentachlorophenol (PCP)-containing synthetic waste was examined. With a waste containing some sugars, and 40-120 mg/L PCP, laboratory activated sludge required about seven days for acclimation. However, the prior addition of a quasipure culture of...

Cite
Edgehill RU, Finn RK. Activated sludge treatment of synthetic wastewater containing pentachlorophenol. Biotechnol Bioeng. 1983;25(9):2165-76doi: 10.1002/bit.260250905.
Edgehill, R. U., & Finn, R. K. (1983). Activated sludge treatment of synthetic wastewater containing pentachlorophenol. Biotechnology and bioengineering, 25(9), 2165-76. https://doi.org/10.1002/bit.260250905
Edgehill, R U, and Finn, R K. "Activated sludge treatment of synthetic wastewater containing pentachlorophenol." Biotechnology and bioengineering vol. 25,9 (1983): 2165-76. doi: https://doi.org/10.1002/bit.260250905
Edgehill RU, Finn RK. Activated sludge treatment of synthetic wastewater containing pentachlorophenol. Biotechnol Bioeng. 1983 Sep;25(9):2165-76. doi: 10.1002/bit.260250905. PMID: 18574814.
Copy Download .nbib Format: NLM
Microbial treatment of soil to remove pentachlorophenol.

Applied and environmental microbiology

Edgehill RU, Finn RK.
PMID: 16346232
Appl Environ Microbiol. 1983 Mar;45(3):1122-5. doi: 10.1128/aem.45.3.1122-1125.1983.

Direct inoculation of bacteria capable of degrading pentachlorophenol (PCP) into PCP-contaminated soil was investigated as a prophylactic measure to reduce the hazards of runoffs when spills occur or when wooden poles freshly treated with PCP-containing preservatives are located near...

Cite
Edgehill RU, Finn RK. Microbial treatment of soil to remove pentachlorophenol. Appl Environ Microbiol. 1983;45(3):1122-5doi: 10.1128/aem.45.3.1122-1125.1983.
Edgehill, R. U., & Finn, R. K. (1983). Microbial treatment of soil to remove pentachlorophenol. Applied and environmental microbiology, 45(3), 1122-5. https://doi.org/10.1128/aem.45.3.1122-1125.1983
Edgehill, R U, and Finn, R K. "Microbial treatment of soil to remove pentachlorophenol." Applied and environmental microbiology vol. 45,3 (1983): 1122-5. doi: https://doi.org/10.1128/aem.45.3.1122-1125.1983
Edgehill RU, Finn RK. Microbial treatment of soil to remove pentachlorophenol. Appl Environ Microbiol. 1983 Mar;45(3):1122-5. doi: 10.1128/aem.45.3.1122-1125.1983. PMID: 16346232; PMCID: PMC242416.
Copy Download .nbib Format: NLM
INSULIN ANTIBODY VARIATIONS IN RABBITS AND GUINEA PIGS AND MULTIPLE ANTIGENIC DETERMINANTS ON INSULIN.

The Journal of experimental medicine

Arquilla ER, Finn J.
PMID: 19867233
J Exp Med. 1963 Jul 01;118(1):55-71. doi: 10.1084/jem.118.1.55.

1. A method is presented for measuring the degree to which insulin antibodies in one antiserum react with an insoluble insulin complex saturated with antibodies from a different antiserum. 2. Many rabbits produce antibodies which bind to portions of...

Cite
Arquilla ER, Finn J. INSULIN ANTIBODY VARIATIONS IN RABBITS AND GUINEA PIGS AND MULTIPLE ANTIGENIC DETERMINANTS ON INSULIN. J Exp Med. 1963;118(1):55-71doi: 10.1084/jem.118.1.55.
Arquilla, E. R., & Finn, J. (1963). INSULIN ANTIBODY VARIATIONS IN RABBITS AND GUINEA PIGS AND MULTIPLE ANTIGENIC DETERMINANTS ON INSULIN. The Journal of experimental medicine, 118(1), 55-71. https://doi.org/10.1084/jem.118.1.55
Arquilla, E R, and Finn, J. "INSULIN ANTIBODY VARIATIONS IN RABBITS AND GUINEA PIGS AND MULTIPLE ANTIGENIC DETERMINANTS ON INSULIN." The Journal of experimental medicine vol. 118,1 (1963): 55-71. doi: https://doi.org/10.1084/jem.118.1.55
Arquilla ER, Finn J. INSULIN ANTIBODY VARIATIONS IN RABBITS AND GUINEA PIGS AND MULTIPLE ANTIGENIC DETERMINANTS ON INSULIN. J Exp Med. 1963 Jul 01;118(1):55-71. doi: 10.1084/jem.118.1.55. PMID: 19867233; PMCID: PMC2137573.
Copy Download .nbib Format: NLM
Expanding the coordination cage: a ruthenium(II)-polypyridine complex exhibiting high quantum yields under ambient conditions.

Inorganic chemistry

Schramm F, Meded V, Fliegl H, Fink K, Fuhr O, Qu Z, Klopper W, Finn S, Keyes TE, Ruben M.
PMID: 19507851
Inorg Chem. 2009 Jul 06;48(13):5677-84. doi: 10.1021/ic802040v.

A mononuclear ruthenium(II) polypyridyl complex with an enlarged terpyridyl coordination cage was synthesized by the formal introduction of a carbon bridge between the coordinating pyridine rings. Structurally, the ruthenium(II) complex shows an almost perfect octahedral N6 coordination around the...

Cite
Schramm F, Meded V, Fliegl H, et al. Expanding the coordination cage: a ruthenium(II)-polypyridine complex exhibiting high quantum yields under ambient conditions. Inorg Chem. 2009;48(13):5677-84doi: 10.1021/ic802040v.
Schramm, F., Meded, V., Fliegl, H., Fink, K., Fuhr, O., Qu, Z., Klopper, W., Finn, S., Keyes, T. E., & Ruben, M. (2009). Expanding the coordination cage: a ruthenium(II)-polypyridine complex exhibiting high quantum yields under ambient conditions. Inorganic chemistry, 48(13), 5677-84. https://doi.org/10.1021/ic802040v
Schramm, Frank, et al. "Expanding the coordination cage: a ruthenium(II)-polypyridine complex exhibiting high quantum yields under ambient conditions." Inorganic chemistry vol. 48,13 (2009): 5677-84. doi: https://doi.org/10.1021/ic802040v
Schramm F, Meded V, Fliegl H, Fink K, Fuhr O, Qu Z, Klopper W, Finn S, Keyes TE, Ruben M. Expanding the coordination cage: a ruthenium(II)-polypyridine complex exhibiting high quantum yields under ambient conditions. Inorg Chem. 2009 Jul 06;48(13):5677-84. doi: 10.1021/ic802040v. PMID: 19507851.
Copy Download .nbib Format: NLM
The changing world of family medicine: the new view from Cheyenne Mountain.

Annals of family medicine

Steiner E, Bliss E, Cadwallader K, Steyer TE, Clements DS, Devoe JE, Fink K, Khubesrian M, Lyons P, Steiner E, Weismiller D.
PMID: 24445095
Ann Fam Med. 2014 Jan-Feb;12(1):3-5. doi: 10.1370/afm.1621.

No abstract available.

Cite
Steiner E, Bliss E, Cadwallader K, et al. The changing world of family medicine: the new view from Cheyenne Mountain. Ann Fam Med. 2014;12(1):3-5doi: 10.1370/afm.1621.
Steiner, E., Bliss, E., Cadwallader, K., Steyer, T. E., Clements, D. S., Devoe, J. E., Fink, K., Khubesrian, M., Lyons, P., Steiner, E., & Weismiller, D. (2014). The changing world of family medicine: the new view from Cheyenne Mountain. Annals of family medicine, 12(1), 3-5. https://doi.org/10.1370/afm.1621
Steiner, Elizabeth, et al. "The changing world of family medicine: the new view from Cheyenne Mountain." Annals of family medicine vol. 12,1 (2014): 3-5. doi: https://doi.org/10.1370/afm.1621
Steiner E, Bliss E, Cadwallader K, Steyer TE, Clements DS, Devoe JE, Fink K, Khubesrian M, Lyons P, Steiner E, Weismiller D. The changing world of family medicine: the new view from Cheyenne Mountain. Ann Fam Med. 2014 Jan-Feb;12(1):3-5. doi: 10.1370/afm.1621. PMID: 24445095; PMCID: PMC3896529.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 584 entries